A world leading health company is seeking novel antibiotic-free microbial expression systems for production of a wide range of biologics including recombinant proteins, peptides, antigens, Fc-fusion proteins, and monoclonal antibodies. Additionally, the team is looking for partners and/or technologies to support removal of AMR genes from bacterial genomes through genetic modification.
Approaches of Interest:
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.